[LGND] YoY Quarter Result on 31-Dec-2009 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
03-Mar-2010
Financial Year
2009
Quarter
31-Dec-2009 [#Q4]
Profit Trend
QoQ- 68.39%
YoY- 104.36%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Revenue 13,635 12,936 3,940 13,977 12,389 5,770 34,130 -14.16%
PBT 950 5,997 -1,587 1,034 -73,964 -8,240 4,506 -22.83%
Tax -1,636 495 -3,935 -1,535 -234 -2,918 -36,124 -40.26%
NP 1,063 5,502 4,503 3,036 -69,627 5,938 141,364 -55.70%
Tax Rate 172.21% -8.25% - 148.45% - - 801.69% -
Total Cost 12,572 7,434 -563 10,941 82,016 -168 -107,234 -
Ratio Analysis
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
NP Margin 7.80 42.53 114.29 21.72 -562.01 102.91 414.19 -48.38%
Per Share
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
EPS 0.05 0.28 0.23 0.16 -4.37 0.36 10.52 -58.96%
EPS Diluted 0.05 0.28 0.23 0.16 -4.37 0.36 10.52 -58.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.